![]() |
|
||||
![]() |
|
||||
Since the identification of C. pneumoniae as its own species of Chlamydiaceae in 1989, it has been implicated as the culprit for a variety of health issues, from asthma, to respiratory tract infections and even atherosclerosis, the build-up of plaque in the arteries. “When I first heard of the connection between atherosclerosis and C. pneumoniae, I was skeptical, but research, including in my own lab, has borne out that connection,” Dr. Dean explains. “It isn’t that much of a stretch as you would think for the organism to get into the lungs, migrate from the lungs to the blood, from the blood into compromised tissues, and then release the organism to infect other cells in the tissue, including the coronary arteries involved in heart disease.” While there are a variety of studies still teasing out the connection between C. pneumoniae and heart disease, and whether or not the infection occurs because there is already damage to the arteries or is an instigator in that damage, conclusive serologic studies suggest that by the time people reach adulthood, 90 percent of them have been exposed to the organism, most likely in the more common form of a respiratory tract infection, including simple cold-like symptoms. “As a respiratory pathogen, you can imagine that it’s going to spread. People cough, eject the organism and pass it on to someone else. It may not cause pneumonia, but it certainly can result in a respiratory infection,” Dr. Dean says. As a latecomer to be identified as part of the Chlamydiaceae family, C. pneumoniae is still a fairly poorly understood pathogen. “Although C. pneumoniae wasn’t discovered until just 20 years ago, which is a relatively short period of time from a research perspective, it doesn’t mean that it didn’t exist before then,” explains Dr. Dean.
|
|||||
|
© 2005 Children's Hospital Oakland Research Institute |
|||||